NDC Product
Human Prescription DrugZenpep NDC 73562-110
- Generic Name
- Pancrelipase Lipase, Pancrelipase Protease, Pancrelipase Amylase
- Dosage Form
- Capsule, Delayed Release
- Route
- Oral
- Marketing
- BLA
Active Listing
Lipase 40,000 UNT / amylase 168,000 UNT / protease 126,000 UNT Delayed Release Oral Capsule
RxNorm 1995477 NDC Crossover
NDC Directory Crossover & Product Mapping
The following National Drug Codes (NDCs) are directly associated with the clinical concept for Lipase 40,000 UNT / amylase 168,000 UNT / protease 126,000 UNT Delayed Release Oral Capsule (RxCUI 1995477). This crossover tool provides a verified mapping between standardized RxNorm clinical drug definitions and the specific manufactured products listed in the FDA NDC directory.
Healthcare professionals, pharmacists, and data analysts use this list to identify various brand names, labelers, and commercial packaging variations linked to this semantic clinical drug concept. Each entry below represents a commercial product that fulfills the requirements of this specific clinical identifier.
